Daniel Molin
Impact in
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Viral-associated cancers and disorders
- CAR-T cell therapy research
Papers in
-
- Lymphoma Diagnosis and Treatment 54
- Oncology 33
- Viral-associated cancers and disorders 14
- Cancer Immunotherapy and Biomarkers 7
- Co-authors
- Gunilla Enblad (38 shared papers)Christer Sundström (12 shared papers)John Radford (11 shared papers)Craig H. Moskowitz (9 shared papers)Margaret A. Shipp (9 shared papers)Pier Luigi Zinzani (9 shared papers)Philippe Armand (8 shared papers)Nathalie A. Johnson (8 shared papers)
- Journals
- British Journal of Haematology (10 papers)Blood (10 papers)European Journal Of Haematology (6 papers)Journal of Clinical Oncology (4 papers)Acta Oncologica (3 papers)
- Partner nations
- SwedenDenmarkUnited States
In The Last Decade
Daniel Molin
74 papers receiving 2.6k citations
Daniel Molin's Hit Papers
Peers
Comparison fields: 5 of 83
- Pathology and Forensic Medicine 1.3k
- Oncology 1.4k
- Immunology 872
- Genetics 236
- Neurology 306
Countries citing papers authored by Daniel Molin
This map shows the geographic impact of Daniel Molin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Molin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Molin more than expected).
Fields of papers citing papers by Daniel Molin
This network shows the impact of papers produced by Daniel Molin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Molin. The network helps show where Daniel Molin may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Molin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma Hit paper breakdown → | 2017 | 721 |
| 2 | 2019 | 233 | |
| 3 | 2002 | 150 | |
| 4 | 2007 | 132 | |
| 5 | 2001 | 108 | |
| 6 | 2011 | 80 | |
| 7 | 2013 | 67 | |
| 8 | 2007 | 66 | |
| 9 | 2003 | 58 | |
| 10 | 2008 | 55 | |
| 11 | 2023 | 49 | |
| 12 | 2016 | 47 | |
| 13 | 2010 | 38 | |
| 14 | 2002 | 34 | |
| 15 | 2006 | 30 | |
| 16 | 2018 | 30 | |
| 17 | 2007 | 29 | |
| 18 | 2018 | 27 | |
| 19 | 2004 | 25 | |
| 20 | 2005 | 25 |
About Daniel Molin
Daniel Molin is a scholar working on Pathology and Forensic Medicine, Oncology, Pulmonary and Respiratory Medicine, Immunology and Neurology, having authored 78 papers that have together received 2.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (54 papers), Viral-associated cancers and disorders (14 papers), Lung Cancer Treatments and Mutations (14 papers), CNS Lymphoma Diagnosis and Treatment (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), Eosinophilic Disorders and Syndromes (7 papers), Mast cells and histamine (6 papers) and Chronic Lymphocytic Leukemia Research (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.3k citations), Oncology (1.4k citations), Immunology (872 citations), Genetics (236 citations) and Neurology (306 citations). Daniel Molin has collaborated with scholars based in Sweden, Denmark and United States. Frequent co-authors include Gunilla Enblad, Christer Sundström, John Radford, Craig H. Moskowitz, Margaret A. Shipp, Pier Luigi Zinzani, Philippe Armand, Nathalie A. Johnson, Akihiro Tomita and Vincent Ribrag. Their work appears in journals such as British Journal of Haematology, Blood, European Journal Of Haematology, Journal of Clinical Oncology and Acta Oncologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.